Back to Trades
Other4
Moderna, Inc.
MRNA
Total Value
$24.6K
Company Information
- Company Name
- Moderna, Inc.
- Ticker Symbol
- MRNA
- CIK
- 0001682852
Insider Information
- Name
- Hoge Stephen
- Role
- President
- Location
- CAMBRIDGE, MA
Officer
Filing Details
- Filing Date
- Dec 1, 2025
- Transaction Date
- Nov 26, 2025
- Accession Number
- 0001682852-25-000078
- Form Type
- 4
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Nov 26, 2025 | Common Stock | 1,437 | — | Exercise | — |
| Nov 26, 2025 | Common Stock | 695 | $24.75 | Tax Withholding | $17.2K |
| Nov 28, 2025 | Common Stock | 610 | — | Exercise | — |
| Nov 28, 2025 | Common Stock | 295 | $25.01 | Tax Withholding | $7.4K |
Derivative Transactions
| Date | Security | Shares | Exercise Price | Type | Value |
|---|---|---|---|---|---|
| Nov 26, 2025 | Derivative | 1,437 | — | Exercise | — |
| Nov 28, 2025 | Derivative | 610 | — | Exercise | — |
Footnotes
- (F1)Restricted stock units convert into common stock on a one-for-one basis.
- (F2)Represents shares withheld at the election of the Reporting Person to satisfy tax withholding obligations in connection with the vest of restricted stock units.
- (F3)These shares are owned directly by a trust for the benefit of Dr. Hoge's spouse and children, of which his spouse is a trustee. The reporting person disclaims Section 16 beneficial ownership of these securities, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for Section 16 or any other purpose.
- (F4)25% of the shares subject to this restricted stock unit award vested on February 27, 2025 with the remainder vesting in twelve (12) equal quarterly installments thereafter.
- (F5)25% of the shares subject to this restricted stock unit award vested on February 28, 2024 with the remainder vesting in twelve (12) equal quarterly installments thereafter.